Evidence map›Paper›PMID 38579005›Full record

ArticleScience advances2024

Exceptional-point-enhanced phase sensing.

Wenbo Mao, Zhoutian Fu, Yihang Li, Fu Li, Lan Yang

Open access · goldAbstract read
In one paragraph

Article in Science advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
27.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 81 citations in OpenAlex.

  1. Article
  2. Article
  3. A Dual-Channel Synergistic Ultrasensitive Biosensor for Tumor Liquid Biopsy.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Exceptional points in a passive strip waveguide.Nanophotonics (Berlin, Germany) · 2025
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Wenbo MaoDepartment of Electrical and Systems Engineering, Washington University, St. Louis, MO 63130, USA.ORCID 0000-0002-7406-0992
Zhoutian FuDepartment of Electrical and Systems Engineering, Washington University, St. Louis, MO 63130, USA.
Yihang LiDepartment of Electrical and Systems Engineering, Washington University, St. Louis, MO 63130, USA.
Fu LiDepartment of Electrical and Systems Engineering, Washington University, St. Louis, MO 63130, USA.
Lan YangDepartment of Electrical and Systems Engineering, Washington University, St. Louis, MO 63130, USA.ORCID 0000-0002-9052-0450
Washington University in St. Louis · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Optical sensors, crucial in diverse fields like gravitational wave detection, biomedical imaging, and structural health monitoring, rely on optical phase to convey valuable information. Enhancing sensitivity is important for detecting weak signals. Exceptional points (EPs), identified in non-Hermitian systems, offer great potential for advanced sensors, given their marked response to perturbations. However, strict physical requirements for operating a sensor at EPs limit broader applications. Here, we introduce an EP-enhanced sensing platform featuring plug-in external sensors separated from an EP control unit. EPs are achieved without modifying the sensor, solely through control-unit adjustments. This configuration converts and amplifies optical phase changes into quantifiable spectral features. By separating sensing and control functions, we expand the applicability of EP enhancement to various conventional sensors. As a proof-of-concept, we demonstrate a sixfold reduction in the detection limit of fiber-optic strain sensing using this configuration. This work establishes a universal platform for applying EP enhancement to diverse phase-dependent structures, promising ultrahigh-sensitivity sensing across various applications.

Identifiers

PMID38579005
PMCPMC10997194
OpenAlexW4393973963

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.